Bertelsmann India Investments led a $29m Series B round in Inito Health.

Bertelsmann India Investments, an Indian-based investment firm, led a $29m Series B round in Inito Health, a technology company that develops at‑home health diagnostics devices and software, initially focused on fertility hormone monitoring, with participation from Fireside Ventures and Kyra Ventures. “The future of healthcare lies at the intersection of deep science, AI, and personal wellness — and that’s exactly where Inito is leading,” Swati Muraka, Bertelsmann India Investments' Principal.